Eli Lilly has become one of the most closely watched stocks in big pharma after a strong multi year run, and the key question now is whether the cash the business can generate actually supports where ...
Source LinkEli Lilly has become one of the most closely watched stocks in big pharma after a strong multi year run, and the key question now is whether the cash the business can generate actually supports where ...
Source Link
Comments